-
Something wrong with this record ?
Prescription versus over-the-counter venotonics: HPLC-DAD and static digestive model simulation comparison
R. Novotny, M. Orsak, J. Lachman, K. Zora, B. Novotna, J. Hlubocky, J. Pitha, L. Janousek
Language English Country Italy
Document type Journal Article, Comparative Study
- MeSH
- Models, Biological MeSH
- Diosmin analysis MeSH
- Hesperidin analysis MeSH
- Nonprescription Drugs * chemistry MeSH
- Prescription Drugs analysis chemistry MeSH
- Humans MeSH
- Tablets MeSH
- Chromatography, High Pressure Liquid MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Comparative Study MeSH
BACKGROUND: Venotonics are a class of therapeutically active molecules that have vaso-protective effects. They are used to alleviate venous diseases and disorders, particularly venous insufficiency. We compared the composition of prescription versus over-the-counter (OTC) venotonics using high-performance liquid chromatography with UV detection (HPLC-DAD) and simulating their digestion using a static digestive model. METHODS: From each drug, five tablets were weighed. A homogenate was prepared, and 25 mg of crushed homogenized tablets were weighed into 25 ml volumetric flasks. Dissolved in MeOH and added two drops of saturated NaOH solution. The samples were filtered into vials (Teflon, 0.45 μm) and used for analysis. An Ultimate 3000 HPLC system (Thermo Fisher Scientific, Waltham, MA, USA) consisting of a quaternization pump, autosampler, column thermostat and DAD (UV/VIS detector) was used. The composition of the mobile phase proceeded in a linear gradient from 30% methanol and 70% phosphoric acid (0.15%) in water at time t=0 min. to 80% methanol and 20% phosphoric acid (0.15%) at time t=15 min., at a constant mobile phase flow rate of 1.2 mL/min. Detection was performed using a DAD detector in the 190-450 nm wavelength range. The content of monitored flavonoids was calculated from peaks at a wavelength of 277 nm, in which both flavonoids have their absorption maxima. The static digestive model was used to simulate the digestive phase from the oral cavity to the corresponding intestinal phase. RESULTS: The content of diosmin and hesperidin (mg per table) for a prescription drug: Detralex: 480 mg, 26 mg. The content of diosmin and hesperidin (mg per tablet) for OTC drugs: Venostop: 502 mg, 48 mg, Diosminol: 520 mg, 50 mg, Devenal: 496 mg, 49 mg, Diohes: 493 mg, 46 mg. Digestion did not affect the solubility of all tested drugs. The active substances could not be determined in the non-alkalized sample. After alkalization, part of the insoluble matter was visibly dissolved and converted to a yellow flavonoid complex. Neither diosmin nor hesperidin could be identified afterwards. CONCLUSIONS: Our experimental results show that the contents of both listed active substances, diosmin and hesperidin, met the declared amounts in all tested medicaments. Digestion simulation showed identical behaviour in prescription and OTC venotonics. The active substances could not be determined in the non-alkalized sample. Digestion did not affect the solubility of the tested drugs.
1st Faculty of Medicine Charles University Prague Czech Republic
2nd Department of Cardiovascular Surgery General University Hospital Prague Czech Republic
Department of Cardiology Institute for Clinical and Experimental Medicine Prague Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003961
- 003
- CZ-PrNML
- 005
- 20250206104825.0
- 007
- ta
- 008
- 250121s2024 it f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.23736/S0392-9590.24.05291-X $2 doi
- 035 __
- $a (PubMed)39625184
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a it
- 100 1_
- $a Novotny, Robert $u Transplantation Surgery Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic - novr@ikem.cz
- 245 10
- $a Prescription versus over-the-counter venotonics: HPLC-DAD and static digestive model simulation comparison / $c R. Novotny, M. Orsak, J. Lachman, K. Zora, B. Novotna, J. Hlubocky, J. Pitha, L. Janousek
- 520 9_
- $a BACKGROUND: Venotonics are a class of therapeutically active molecules that have vaso-protective effects. They are used to alleviate venous diseases and disorders, particularly venous insufficiency. We compared the composition of prescription versus over-the-counter (OTC) venotonics using high-performance liquid chromatography with UV detection (HPLC-DAD) and simulating their digestion using a static digestive model. METHODS: From each drug, five tablets were weighed. A homogenate was prepared, and 25 mg of crushed homogenized tablets were weighed into 25 ml volumetric flasks. Dissolved in MeOH and added two drops of saturated NaOH solution. The samples were filtered into vials (Teflon, 0.45 μm) and used for analysis. An Ultimate 3000 HPLC system (Thermo Fisher Scientific, Waltham, MA, USA) consisting of a quaternization pump, autosampler, column thermostat and DAD (UV/VIS detector) was used. The composition of the mobile phase proceeded in a linear gradient from 30% methanol and 70% phosphoric acid (0.15%) in water at time t=0 min. to 80% methanol and 20% phosphoric acid (0.15%) at time t=15 min., at a constant mobile phase flow rate of 1.2 mL/min. Detection was performed using a DAD detector in the 190-450 nm wavelength range. The content of monitored flavonoids was calculated from peaks at a wavelength of 277 nm, in which both flavonoids have their absorption maxima. The static digestive model was used to simulate the digestive phase from the oral cavity to the corresponding intestinal phase. RESULTS: The content of diosmin and hesperidin (mg per table) for a prescription drug: Detralex: 480 mg, 26 mg. The content of diosmin and hesperidin (mg per tablet) for OTC drugs: Venostop: 502 mg, 48 mg, Diosminol: 520 mg, 50 mg, Devenal: 496 mg, 49 mg, Diohes: 493 mg, 46 mg. Digestion did not affect the solubility of all tested drugs. The active substances could not be determined in the non-alkalized sample. After alkalization, part of the insoluble matter was visibly dissolved and converted to a yellow flavonoid complex. Neither diosmin nor hesperidin could be identified afterwards. CONCLUSIONS: Our experimental results show that the contents of both listed active substances, diosmin and hesperidin, met the declared amounts in all tested medicaments. Digestion simulation showed identical behaviour in prescription and OTC venotonics. The active substances could not be determined in the non-alkalized sample. Digestion did not affect the solubility of the tested drugs.
- 650 _2
- $a vysokoúčinná kapalinová chromatografie $7 D002851
- 650 12
- $a léky bez předpisu $x chemie $7 D004366
- 650 _2
- $a tablety $7 D013607
- 650 _2
- $a léky na předpis $x analýza $x chemie $7 D055553
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hesperidin $x analýza $7 D006569
- 650 _2
- $a diosmin $x analýza $7 D004145
- 650 _2
- $a biologické modely $7 D008954
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a srovnávací studie $7 D003160
- 700 1_
- $a Orsak, Matyas $u Department of Chemistry, Faculty of Agrobiology, Food and Natural Resources, University of Life Sciences Prague, Prague, Czech Republic
- 700 1_
- $a Lachman, Jaromir $u Department of Chemistry, Faculty of Agrobiology, Food and Natural Resources, University of Life Sciences Prague, Prague, Czech Republic
- 700 1_
- $a Zora, Kotikova $u Department of Chemistry, Faculty of Agrobiology, Food and Natural Resources, University of Life Sciences Prague, Prague, Czech Republic
- 700 1_
- $a Novotna, Barbora $u Department of Pulmonology, Medicon, Prague, Czech Republic
- 700 1_
- $a Hlubocky, Jaroslav $u Second Department of Cardiovascular Surgery, General University Hospital, Prague, Czech Republic
- 700 1_
- $a Pitha, Jan $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Janousek, Libor $u Transplantation Surgery Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u First Faculty of Medicine, Charles University, Prague, Czech Republic
- 773 0_
- $w MED00002267 $t International angiology $x 1827-1839 $g Roč. 43, č. 5 (2024), s. 469-475
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39625184 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206104820 $b ABA008
- 999 __
- $a ok $b bmc $g 2263605 $s 1239968
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 43 $c 5 $d 469-475 $e - $i 1827-1839 $m International angiology $n Int Angiol $x MED00002267
- LZP __
- $a Pubmed-20250121